Obestatin (Human, Monkey) – RIA Kit

The Obestatin (Human, Monkey) – RIA Kit (Catalog #RK-031-92) is a research reagent supplied by Phoenix Peptide under our specialized ELISA Kits – Assay Kits – RIA Kits category. This item is offered at a regular price of $942 for a package size of 125 tubes.

Storage, Handling & Operational Notes

Transport & Regulatory Notes: This package conforms to the 49 CFR173.421 for expected radioactive material limited quantity, N.O.S. UN2910.

References & Citations: Links to publications that use this kit: Studies from Medical University of Bialystok in the area of thyroid disease described. Pediatrics Week Newspaper July 24, 2010 Alexandridis et al. Obestatin/ghrelin ratio: A new activity index in inflammatory bowel diseases. Inflamm Bowel Dis. 2009 Apr 30. [Epub ahead of print] Germain et al. Ghrelin/obestatin ratio in two populations with low bodyweight: constitutional thinness and anorexia nervosa. Psychoneuroendocrinology. 2009 Apr34(3):413-9. Koca et al. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation. 2008 Oct31(5):329-35. Gao et al. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides. 2008 Oct29(10):1749-54. Nakahara et al. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry. 2008 Aug 164(3):252-5. Aydin et al. Presence of obestatin in breast milk: relationship among obestatin, ghrelin, and leptin in lactating women. Nutrition. 2008 Jul-Aug24(7-8):689-93. Granata et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes. 2008 Apr57(4):967-79. Reinehr et al. Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight. Clin Endocrinol (Oxf). 2008 Feb68(2):304-10. Harada et al. Obestatin, acyl ghrelin, and des-acyl ghrelin responses to an oral glucose tolerance test in the restricting type of anorexia nervosa. Biol Psychiatry. 2008 Jan 1563(2):245-7. Gao et al. Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract. 2008 Jan79(1):e5-6. Huda et al. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond). 2008 Jan32(1):129-35. Ozbay et al. Obestatin is present in saliva: alterations in obestatin and ghrelin levels of saliva and serum in ischemic heart disease BMB Rep. 2008 Jan 3141(1):55-61. Furnes et al. Feeding behavior in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res. 200840(3):279-88. Sedlácková et al. Simultaneous decrease of plasma obestatin and ghrelin levels after a high-carbohydrate breakfast in healthy women. Physiol Res. 200857 Suppl 1:S29-37. Zamrazilová et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res. 200857 Suppl 1:S49-55. Anderwalk-Stadler et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans Am J Physiol Endocrinol Metab. 2007 Nov293(5):E1393-8. Fontenot et al. Obestatin and ghrelin in obese and in pregnant women Peptides. 2007 Oct28(10):1937-44. Guo et al. Circulating Preprandial Ghrelin to Obestatin Ratio Is Increased in Human Obesity J Clin Endocrinol Metab. 2007 May92(5):1875-80. Qi et al. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus Clin Endocrinol (Oxf). 2007 Apr66(4):593-7. Park et al. Obestatin is not elevated or correlated with insulin in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2007 Jan92(1):229-34. Stenström et al. Mechanism of gastric bypass-induced body weight loss: one-year follow-up after micro-gastric bypass in rats. J Gastrointest Surg. 2006 Dec10(10):1384-91.

Related Research Products & Support

For complementary laboratory workflows, explore related items in our catalog: Cholecystokinin (CCK) (26-33), non-sulfated (Human, Rat, Mouse) – Extraction-Free EIA Kit, Cholecystokinin (CCK) (26-33), non-sulfated (Human, Rat, Mouse, Porcine, Canine, Bovine, Chicken) – RIA Kit, and Cholecystokinin (CCK) (26-33), non-sulfated (Human, Rat, Mouse, Porcine, Canine, Bovine, Chicken) – Fluorescent EIA Kit, CE Mark Certified available through Phoenix Peptide. Guaranteed for quality assurance and analytical precision.

Specification / Feature	Details
Catalog Number	RK-031-92
Packaging	125 tubes
Category	ELISA Kits – Assay Kits – RIA Kits
Price / Unit	$942
Intra-Assay CV:	<10%
Inter-Assay CV:	<15%
Sensitivity:	206.1 pg/ml
Specificity:	Peptide %ty
Obestatin (Human, Monkey)	100
Obestatin-Gly-Lys (Human)	33
Obestatin (canine)	8.7
Obestatin (Mouse, Rat)	4
Obestatin-Gly (Mouse, Rat)	0.9
Obestatin (Porcine)	0.09
Obestatin, Des (1-10) (Mouse, Rat)	0
Ghrelin, Prepro (52-75) (Human)	0
Ghrelin, Prepro (101-117) (Human)	0
Ghrelin (Human)	0
Ghrelin (Mouse, Rat)	0
Motilin (Human, Porcine)	0
PYY 3-36 (Human)	0
PYY 3-36 (Rat, Porcine)	0
a-MSH	0
CART 55-102 (Human)	0
AGRP (83-132) (Human)	0
Neuromedin U (Human)	0
Neuropeptide W-23 (Human)	0
Neuropeptide W-30 (Human)	0
Neuropeptide W-23 (Rat, Mouse)	0
Neuropeptide B-23 (NPB-23) Des-Br (Human)	0
Standard Range:	50 – 6400 pg/ml
Radioactivity:	Each kit contains 1.5 µCi of Iodine 125.